Free shipping on all orders over $ 500

LYN-1604 2HCl

Cat. No. M10069

All AbMole products are for research use only, cannot be used for human consumption.

LYN-1604 2HCl Structure
Synonym:

LYN1604

Size Price Availability Quantity
2mg USD 145  USD145 In stock
5mg USD 247  USD247 In stock
10mg USD 375  USD375 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

LYN-1604 is a novel activator of ULK1, inducing cell death involved in ATF3, RAD21, and caspase3, accompanied by autophagy and apoptosis. LYN-1604 has an IC50 of 1.66 μM against MDA-MB-231 cells, and it binds to wild-type ULK1 with a binding affinity in the nanomole range (Kd=291.4 nM). The ULK1 (Y89A) mutant protein caused a sharp decrease in binding affinity with lower response and Kd than wild-type ULK1, ULK1 (K50A) and ULK1 (L53A) mutants.

Protocol (for reference only)
Cell Experiment
Cell lines MDA-MB-231 cells
Preparation method Cells are dispensed in 96-well plates at a density of 5 × 104 cells per mL. After 24 h of incubation, cells are treated with different concentrations of compounds for the indicated time periods. Cell viability is measured by the MTT assay.
Concentrations 0.5, 1.0 and 2.0 μM
Incubation time 24 h
Animal Experiment
Animal models MDA-MB-231 xenograft model (BALB/c nude mice)
Formulation -
Dosages 25 mg/kg, 50 mg/kg, 100 mg/kg
Administration intragastric administration
Chemical Information
Molecular Weight 657.54
Formula C33H45Cl4N3O2
CAS Number 2088939-99-3
Solubility (25°C) Water 90 mg/mL
DMSO 45 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Lan Zhang, et al. Chem Sci. Discovery of a small molecule targeting ULK1-modulated cell death of triple negative breast cancer in vitro and in vivo

[2] Liang Ouyang, et al. Autophagy. A small-molecule activator induces ULK1-modulating autophagy-associated cell death in triple negative breast cancer

Related ULK Products
XST-14

XST-14 is a potent, competitive and highly selective ULK1 inhibitor with an IC50 of 26.6 nM. XST-14 induces autophagy inhibition by reducing the phosphorylation of the ULK1 downstream substrate. XST-14 has antitumor effects.

DCC-3116 

DCC-3116 is an orally active ULK1/2 inhibitor.

DCC-3116

DCC-3116 is a first-in-class, potent and selective inhibitor of ULK1/2 kinases and autophagy. ULK1/2 are kinases that receive and process input from nutrient and stress sensors to initiate autophagy.

MRT68921 

MRT68921 is a potent inhibitor of ULK1 and ULK2, with IC50 values of 2.9 nM and 1.1 nM, respectively.

SBP-7455

SBP-7455 is a dual-Specific ULK1/2 autophagy inhibitor with IC50s of 13 nM and 476 nM for ULK1 and ULK2 in ADP-Glo assay, respectively.

  Catalog
Abmole Inhibitor Catalog




Keywords: LYN-1604 2HCl, LYN1604 supplier, ULK, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.